carteolol has been researched along with Cardiac Hypertrophy in 3 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 5.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| " In this study, we investigated the effect of chronic administration of carteolol (4 mg/kg/day p." | 1.28 | Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR. ( Ieki, K; Kojima, M; Komuro, I; Seko, Y; Sugiyama, T; Takaku, F; Tsuchimochi, H; Yamaoki, K; Yazaki, Y; Yoshizumi, M, 1989) |
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 1.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igawa, T | 1 |
| Ikezono, K | 1 |
| Watanabe, K | 1 |
| Kimura, Y | 1 |
| Rosales, OR | 1 |
| Sander, GE | 1 |
| Roffidal, L | 1 |
| Given, MB | 1 |
| Giles, TD | 1 |
| Ieki, K | 1 |
| Yazaki, Y | 1 |
| Yamaoki, K | 1 |
| Tsuchimochi, H | 1 |
| Yoshizumi, M | 1 |
| Komuro, I | 1 |
| Sugiyama, T | 1 |
| Seko, Y | 1 |
| Takaku, F | 1 |
| Kojima, M | 1 |
3 other studies available for carteolol and Cardiac Hypertrophy
| Article | Year |
|---|---|
Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiomegaly; Carteolol; Dose-Response Relationship, Drug; Drinking; Heart Rat | 1984 |
Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Carteolol; Electrocardiography; Humans; | 1989 |
Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR.
Topics: Adrenergic beta-Antagonists; Animals; Cardiomegaly; Carteolol; Hydroxyproline; Male; Myosins; Propra | 1989 |